Search - tctmd.com

Displaying 61 - 80 of 392

Sort: Relevancy | Date

Presentation TCT 2024

Multicentric Randomized Evaluation of Transcatheter Edge-to-Edge Repair for Severe Isolated Tricuspid Regurgitation: The TRI-FR Trial: Evolution Over Time of Transthoracic Echocardiography Parameters

Presenter: Erwan Donal

October 27, 2024

Presentation TCT 2024

Transcatheter Leaflet Repair for Tricuspid Regurgitation: 1-Year Results From the PASTE Registry

Presenter: Mirjam Wild

October 27, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Daily News

Tricuspid TEER Continues to Offer Benefits Through 3 Years: TRILUMINATE

Caitlin E. Cox

September 12, 2024

News Conference News ESC 2024

Tri.Fr Trial Affirms Quality-of-Life Impact of Tricuspid TEER

Todd Neale

August 31, 2024

Presentation ESC 2024

Multicentric randomized evaluation of a Tricuspid valve Percutaneous Repair System (T-TEER) in the treatment of severe Tricuspid Regurgitation TRI.Fr

Presenter: Erwan Donal

August 31, 2024

News Features

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

L.A. McKeown

August 09, 2024

News Opinion CV Team Dispatch

August 2024 Dispatch for the CV Team

L.A. McKeown

August 01, 2024

News Features

Valvular Heart Disease Has a Diversity Problem

Yael L. Maxwell

July 12, 2024

News Conference News NY Valves 2024

T-TEER for Tricuspid Regurgitation Induces Reverse Remodeling, Works in Tricky Anatomies

Todd Neale

June 07, 2024

News Conference News NY Valves 2024

AV Block Common After Transcatheter Tricuspid Valve Replacement for TR

Michael O'Riordan

June 07, 2024

Presentation NY Valves 2024

Anatomy and Mechanisms of Tricuspid Regurgitation – What The Interventionalist Needs to Know

Presenter: Mark Reisman

June 07, 2024

Presentation NY Valves 2024

Clinical Management of Symptomatic Patients with Severe Tricuspid Regurgitation

Presenter: Sean P. Pinney

June 07, 2024

Presentation NY Valves 2024

Natural History, Pathophysiology and Classification of Tricuspid Regurgitation

Presenter: Yan Topilsky

June 07, 2024

Presentation NY Valves 2024

Percutaneous Treatment of Tricuspid Regurgitation With the Novel TriFlO® Device: First in Human Italian Experience

Presenter: Gian Paolo Ussia

June 06, 2024

Presentation NY Valves 2024

Clinical Implications of Recurrent Tricuspid Regurgitation After Transcatheter Edge-to-Edge Repair: The TRI-SPA Registry

Presenter: Julio Cesar Echarte Morales

June 06, 2024

Presentation NY Valves 2024

Long-Term Follow Up With the DUO Coaptation Valve System for the Percutaneous Treatment of Tricuspid Regurgitation: The TANDEM I Trial

Presenter: Wojtek Wojakowski

June 06, 2024

Presentation NY Valves 2024

Long-Term Outcomes With Medical Therapy, Transcatheter Repair, or Surgery for Isolated Tricuspid Regurgitation: A Systematic Review and Network Meta-Analysis

Presenter: Toshiki Kuno

June 06, 2024

Presentation NY Valves 2024

Residual Tricuspid Regurgitation After Transcatheter Tricuspid Valve Edge-to-Edge Repair: Insights Into the Eurotr Registry

Presenter: Lukas Stolz

June 06, 2024

Presentation NY Valves 2024

Early Feasibility Study of the Laplace TTVR System in Patients With Severe, Symptomatic Tricuspid Regurgitation

Presenter: Thomas E. Waggoner

June 06, 2024

Advertisement

Multicentric Randomized Evaluation of Transcatheter Edge-to-Edge Repair for Severe Isolated Tricuspid Regurgitation: The TRI-FR Trial: Evolution Over Time of Transthoracic Echocardiography Parameters

Transcatheter Leaflet Repair for Tricuspid Regurgitation: 1-Year Results From the PASTE Registry

What’s Going to Be Big at TCT 2024?

Tricuspid TEER Continues to Offer Benefits Through 3 Years: TRILUMINATE

Tri.Fr Trial Affirms Quality-of-Life Impact of Tricuspid TEER

Multicentric randomized evaluation of a Tricuspid valve Percutaneous Repair System (T-TEER) in the treatment of severe Tricuspid Regurgitation TRI.Fr

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

August 2024 Dispatch for the CV Team

Valvular Heart Disease Has a Diversity Problem

T-TEER for Tricuspid Regurgitation Induces Reverse Remodeling, Works in Tricky Anatomies

AV Block Common After Transcatheter Tricuspid Valve Replacement for TR

Anatomy and Mechanisms of Tricuspid Regurgitation – What The Interventionalist Needs to Know

Clinical Management of Symptomatic Patients with Severe Tricuspid Regurgitation

Natural History, Pathophysiology and Classification of Tricuspid Regurgitation

Percutaneous Treatment of Tricuspid Regurgitation With the Novel TriFlO® Device: First in Human Italian Experience

Clinical Implications of Recurrent Tricuspid Regurgitation After Transcatheter Edge-to-Edge Repair: The TRI-SPA Registry

Long-Term Follow Up With the DUO Coaptation Valve System for the Percutaneous Treatment of Tricuspid Regurgitation: The TANDEM I Trial

Long-Term Outcomes With Medical Therapy, Transcatheter Repair, or Surgery for Isolated Tricuspid Regurgitation: A Systematic Review and Network Meta-Analysis

Residual Tricuspid Regurgitation After Transcatheter Tricuspid Valve Edge-to-Edge Repair: Insights Into the Eurotr Registry

Early Feasibility Study of the Laplace TTVR System in Patients With Severe, Symptomatic Tricuspid Regurgitation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content